SB3213 on controlled substance prescriptions passes Illinois Senate with Sen. Ellman's support

During the 104th General Assembly on May 31, 2026, Sen. Laura Ellman (D-21st) voted in favor of SB3213, legislation aimed at revising Illinois law regarding controlled substance prescriptions and their transfers. The Illinois Senate reported that the measure passed, with a 56-0 vote in the Senate.

As stated in the bill's text, the proposal is designated as "ELECTRONIC PRESCRIPTIONS."

The following summary is derived from the bill’s language and includes explanation designed to clarify what the bill would accomplish.

This bill amends Illinois law on prescriptions and transfers for controlled substances. It restricts Schedule II drug prescription transfers to only a single occurrence and bars additional transfers, bringing Illinois practices into alignment with federal policy. Moreover, it establishes that prescribers are not obligated to use electronic prescriptions if doing so would cause delays in a patient's access to medication—such as when pharmacies face inventory issues, drug shortages, or are outside normal retail hours. These policy updates will take effect immediately upon enactment.

The legislative action was recorded as 'House Floor Amendment No. 1 Senate Concurs' for SB3213.

Ellman earned a Bachelor of Science from Grinnell College in 1987.

She has served as the Democratic state senator for Illinois’ 21st Senate District since being elected in 2019, succeeding Michael Connelly in that role.

Legislation in Illinois follows an established multi-step process including introduction in the House or Senate, committee hearings, floor debates, and votes in both chambers before proceeding to the governor for final approval or veto. The General Assembly, operating on a two-year cycle, typically considers thousands of bills per session, with only a limited number advancing to become law.